NexGenix is currently fielding an online survey for patients who have NF1. This research will help us as we seek new therapies for patients with Neurofibromatosis. Participants who complete the survey before October 12th will be entered in a drawing to receive a free iPhone (iPhone service not included). Please click on the link to participate in the survey: Click here to take survey

New York Headquarters:
NexGenix Pharmaceuticals Holdings, Inc.
152 West 57th Street
Suite 11B
New York, New York 10019
Phone (212) 974-3006
Fax (212) 974-1042

San Francisco Laboratory:
NexGenix Pharmaceuticals Holdings, Inc.
849 Mitten Road
Suite 104
Burlingame, California 94010
Phone (650) 697-8500
Fax (650) 697-8530